Xavier Padanilam

1.5k total citations
17 papers, 732 citations indexed

About

Xavier Padanilam is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Xavier Padanilam has authored 17 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 12 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Xavier Padanilam's work include Tuberculosis Research and Epidemiology (16 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers) and Pneumonia and Respiratory Infections (7 papers). Xavier Padanilam is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers) and Pneumonia and Respiratory Infections (7 papers). Xavier Padanilam collaborates with scholars based in South Africa, United States and Netherlands. Xavier Padanilam's co-authors include Graeme Meintjes, Gary Maartens, Jennifer Hughes, Francesca Conradie, Norbert Ndjeka, Kathryn Schnippel, Hannetjie Ferreira, Paul D. van Helden, Julian te Riele and Nazir Ismail and has published in prestigious journals such as The Lancet, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Xavier Padanilam

17 papers receiving 709 citations

Peers

Xavier Padanilam
James C.M. Brust United States
Alberto Piubello Belgium
M. Gninafon Benin
Nonkqubela Bantubani South Africa
Sundari Mase United States
Gregory Symons South Africa
Lorenzo Guglielmetti France
Ronelle Moodliar United Kingdom
Ilaria Motta Italy
R. Williams United Kingdom
James C.M. Brust United States
Xavier Padanilam
Citations per year, relative to Xavier Padanilam Xavier Padanilam (= 1×) peers James C.M. Brust

Countries citing papers authored by Xavier Padanilam

Since Specialization
Citations

This map shows the geographic impact of Xavier Padanilam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Padanilam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Padanilam more than expected).

Fields of papers citing papers by Xavier Padanilam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Padanilam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Padanilam. The network helps show where Xavier Padanilam may publish in the future.

Co-authorship network of co-authors of Xavier Padanilam

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Padanilam. A scholar is included among the top collaborators of Xavier Padanilam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Padanilam. Xavier Padanilam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Evans, Denise, Kamban Hirasen, Lawrence Long, et al.. (2024). Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis. PLoS ONE. 19(10). e0309034–e0309034. 4 indexed citations
2.
Ndjeka, Norbert, Jonathon R. Campbell, Graeme Meintjes, et al.. (2022). Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study. The Lancet Infectious Diseases. 22(7). 1042–1051. 44 indexed citations
3.
4.
Ndjeka, Norbert, Francesca Conradie, Graeme Meintjes, et al.. (2020). Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?. European Respiratory Journal. 56(1). 2001369–2001369. 3 indexed citations
5.
Ndjeka, Norbert, Jennifer Hughes, Anja Reuter, et al.. (2020). Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?. The International Journal of Tuberculosis and Lung Disease. 24(10). 1073–1080. 17 indexed citations
6.
Ndjeka, Norbert, Kathryn Schnippel, Iqbal Master, et al.. (2018). High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen. European Respiratory Journal. 52(6). 1801528–1801528. 80 indexed citations
7.
Schnippel, Kathryn, Norbert Ndjeka, Gary Maartens, et al.. (2018). Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study. The Lancet Respiratory Medicine. 6(9). 699–706. 162 indexed citations
8.
Karstaedt, Alan, et al.. (2018). Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa. The International Journal of Tuberculosis and Lung Disease. 22(12). 1469–1474. 9 indexed citations
9.
Sánchez‐Montalvá, Adrián, Vivian Cox, Jennifer Furin, et al.. (2018). QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment. The International Journal of Tuberculosis and Lung Disease. 22(12). 1411–1421. 22 indexed citations
10.
11.
Ndjeka, Norbert, Francesca Conradie, Kathryn Schnippel, et al.. (2015). Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. The International Journal of Tuberculosis and Lung Disease. 19(8). 979–985. 101 indexed citations
12.
13.
Pietersen, Elize, Elisa H. Ignatius, Elizabeth M. Streicher, et al.. (2014). Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study. The Lancet. 383(9924). 1230–1239. 162 indexed citations
14.
15.
Shean, Karen, Elizabeth M. Streicher, Greg Symons, et al.. (2013). Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa. PLoS ONE. 8(5). e63057–e63057. 69 indexed citations
16.
17.
Janssen, Saskia, Xavier Padanilam, Rianna Louw, et al.. (2012). How Many Sputum Culture Results Do We Need To Monitor Multidrug-Resistant-Tuberculosis (MDR-TB) Patients during Treatment?. Journal of Clinical Microbiology. 51(2). 644–646. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James C.M. Brust Breakdown of academic impact, for papers by Alberto Piubello Breakdown of academic impact, for papers by M. Gninafon Breakdown of academic impact, for papers by Nonkqubela Bantubani Breakdown of academic impact, for papers by Sundari Mase Breakdown of academic impact, for papers by Gregory Symons Breakdown of academic impact, for papers by Lorenzo Guglielmetti Breakdown of academic impact, for papers by Ronelle Moodliar Breakdown of academic impact, for papers by Ilaria Motta Breakdown of academic impact, for papers by R. Williams
Rankless by CCL
2026